Efficacy and safety of BuMA drug-eluting stent in long coronary lesion treatment
GAN Jian-ting
YUAN jun
LU Zheng-de
XU Guang-ma
Abstract：Objective The aim of this study is to compare the efficacy and safety of BuMA drug-eluting stents with imported sirolimus-eluting stents in the treatment of long coronary artery lesion of non-ST-segment elevation acute coronary syndrome (NSTE-ACS).Methods A total of 131 patients with NSTE-ACS who underwent percutaneous coronary intervention (PCI) and had long coronary lesions (defined as >20 mm) were included. Patients were assigned randomly to be treated with BuMA drug-eluting stent (n=67) or imported sirolimus-eluting stents (n=64). The incidence of in-stent restenosis (ISR) and late stent thrombosis were observed by coronary angiography performed during follow-up period from 9 to 12 months. The incidence of recurrence of angina pectoris and major adverse cardiac events (MACE) including cardiac death, non-fatal myocardial infarction, and target vessel revascularization (TVR) at 12 months was collected.Results There were no significant differences in the clinical data, stent diameter, stent length and target lesion characteristics between the two groups. There was no statistically significant difference in the incidence of restenosis between the two groups (P>0.05). There were no significant differences in cardiac death, nonfatal myocardial infarction and target lesion revascularization between the two groups after 12 months of follow-up (P>0.05).Conclusions As imported sirolimus-eluting stents, BuMA drug-eluting stents for long coronary lesions is safe and effective.
Keywords：Non-ST-segment elevation acute coronary syndromeDrug-eluting stentLong coronary lesionPercutaneous coronary intervention
Publication Date：2017-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 671-673 )